Interaction between murine type-C virus RNA-directed DNA polymerases and rifamycin derivatives.
D000818:Animals; D001358:Avian Sarcoma Viruses / Q000187:drug effects / Q000201:enzymology*; D001665:Binding Sites; D002250:Carbon Radioisotopes; D002499:Centrifugation, Density Gradient; D002848:Chromatography, DEAE-Cellulose; D002852:Chromatography, Ion Exchange; D003597:Cytosine Nucleotides; D004591:Electrophoresis, Polyacrylamide Gel; D009052:Leukemia Virus, Murine / Q000187:drug effects / Q000201:enzymology*; D051379:Mice; D008970:Molecular Weight; D012367:RNA, Viral; D012194:RNA-Directed DNA Polymerase / Q000302:isolation & purification; D051381:Rats; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D013698:Templates, Genetic; D013942:Thymine Nucleotides; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D003597:Cytosine Nucleotides; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D012294:Rifamycins; D013942:Thymine Nucleotides; D014316:Tritium; D012194:RNA-Directed DNA Polymerase